Mecasermin (Keck Graduate Institute)

美卡舍明 (Keck Graduate Institute)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMecasermin (Keck Graduate Institute)
Drug Alias NameMecasermina (Keck Graduate Institute)Mecaserminum (Keck Graduate Institute)mecasermin, recombinant human insulin-like growth factor-1
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInsulin-like growth factor I receptor agonists
TargetsInsulin-like growth factor I receptor
Therapy Area/IndicationsRett Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending
Highest Status in ChinaN/A
Originator CompaniesKeck Graduate Institute Of Claremont, California
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKeck Graduate Institute Of Claremont, California
Active IndicationsN/A
Inactive IndicationsRett Syndrome

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG